Induction of autophagic cell death in malignant glioma cells by arsenic trioxide

Cancer Research

Volumn 63, Issue 9, 2003, Pages 2103-2108

  Kanzawa, Takao ^a   Kondo, Yasuko ^a   Ito, Hideaki ^a   Kondo, Seiji ^a   Germano, Isabelle ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; BAFILOMYCIN A1; CASPASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL CYCLE G2 PHASE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; ELECTRON MICROSCOPY; GLIOBLASTOMA; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; TUMOR CELL LINE;

AMINO ACID CHLOROMETHYL KETONES; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; AUTOPHAGY; CASPASES; CELL DIVISION; CYTOPLASM; DRUG INTERACTIONS; ENZYME INHIBITORS; G2 PHASE; GLIOMA; HUMANS; MACROLIDES; MITOSIS; OXIDES; TUMOR CELLS, CULTURED;

EID: 0038743077     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. 3 exerts dose-dependent dual effects on APL cells. Blood, 89: 3345-3353, 1997
2. Soignet, S. L., Maslak, P., Wang, Z. G., Jhanwar, S., Calleja, E., Dardashti, L. J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D. A., Pandolfi, P. P., and Warrell, R. P., Jr. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med., 339: 1341-1348, 1998
3. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood, 89: 3354-3360, 1997
4. Zhu, J., Koken, M. H., Quignon, F., Chelbi-Alix, M. K., Degos, L., Wang, Z. Y., Chen, Z., and de The, H. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA, 94: 3978-3983, 1997
5. Mahieux, R., Pise-Masison, C., Gessain, A., Brady, J. N., Olivier, R., Perret, E., Misteli, T., and Nicot, C. Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage. Blood, 98: 3762-3769, 2001
6. Park, J. W., Choi, Y. J., Jang, M. A., Baek, S. H., Lim, J. H., Passaniti, T., and Kwon, T. K. Arsenic trioxide induces G2/M growth arrest and apoptosis after caspase-3 activation and bcl-2 phosphorylation in promonocytic U937 cells. Biochem. Biophys. Res. Commun., 286: 726-734, 2001
7. Perkins, C., Kim, C. N., Fang, G., and Bhalla, K. N. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L). Blood, 95: 1014-1022, 2000
8. Akao, Y., Mizoguchi, H., Kojima, S., Naoe, T., Ohishi, N., and Yagi, K. Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein. Br. J. Haematol., 102: 1055-1060, 1998
9. Dai, J., Weinberg, R. S., Waxman, S., and Jing, Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood, 93: 268-277, 1999
10. Kitamura, K., Minami, Y., Yamamoto, K., Akao, Y., Kiyoi, H., Saito, H., and Naoe, T. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia (Baltimore), 14: 1743-1750, 2000
11. Huang, X. J., Wiemik, P. H., Klein, R. S., and Gallagher, R. E. Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases. Med. Oncol., 16: 58-64, 1999
12. Gianni, M., and de The, H. In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARα protein and the PML retargeting on PML-nuclear bodies. Leukemia (Baltimore), 13: 739-749, 1999
13. Rousselot, P., Labaume, S., Marolleau, J. P., Larghero, J., Noguera, M. H., Brouet, J. C., and Fermand, J. P. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res., 59: 1041-1048, 1999
14. Park, W. H., Seol, J. G., Kim, E. S., Hyun, J. M., Jung, C. W., Lee, C. C., Kim, B. K., and Lee, Y. Y. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res., 60: 3065-3071, 2000
15. Murgo, A. J. Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies. Oncologist, 6: 22-28, 2001
16. Akao, Y., Nakagawa, Y., and Akiyama, K. Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett., 455: 59-62, 1999
17. Shen, Z. Y., Shen, J., Cai, W. J., Hong, C., and Zheng, M. H. The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells. Int. J. Mol. Med., 5: 155-158, 2000
18. 3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res., 61: 5432-5440, 2001
19. Traganos, F., and Darzynkiewicz, Z. Lysosomal proton pump activity: supravital cell staining with acridine orange differentiates leukocyte subpopulations. Methods Cell Biol., 41: 185-194, 1994
20. Stankiewicz, M., Jonas, W., Hadas, E., Cabaj, W., and Douch, P. G. Supravital staining of eosinophils. Int. J. Parasitol., 26: 445-446, 1996
21. Paglin, S., Hollister, T., Delohery, T., Hackett, N., McMahill, M., Sphicas, E., Domingo, D., and Yahalom, J. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res., 61: 439-444, 2001
22. Komata, T., Kondo, Y., Koga, S., Ko, S. C., Chung, L. W., and Kondo, S. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53. Gene Ther., 7: 2071-2079, 2000
23. Bursch, W., Ellinger, A., Gerner, C., Frohwein, U., and Schulte-Hermann, R. Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann. N. Y. Acad. Sci., 926: 1-12, 2000
24. Bursch, W., Hochegger, K., Torok, L., Marian, B., Ellinger, A., and Hermann, R. S. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J. Cell Sci., 113: 1189-1198, 2000
25. Shi, Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell., 9: 459-470, 2002
26. Saeki, K., Yuo, A., Okuma, E., Yazaki, Y., Susin, S. A., Kroemer, G., and Takaku, F. Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells. Cell Death Differ., 7: 1263-1269, 2000
27. Bursch, W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ., 8: 569-581, 2001
28. Lockshin, R. A., and Zakeri, Z. Caspase-independent cell deaths. Curr. Opin. Cell Biol., 14: 727-733, 2002
29. Zaidi, A. U., McDonough, J. S., Klocke, B. J., Latham, C. B., Kormeyer, S. J., Flavell, R. A., Schmidt, R. E., and Roth, K. A. Chloroquine-induced neuronal cell death is p53 and Bcl-2 family-dependent but caspase independent. J. Neuropathol. Exp. Neurol., 60: 937-945, 2001
30. Bursch, W., Ellinger, A., Kienzl, H., Torok, L., Pandey, S., Sikorska, M., Walker, R., and Hermann, R. S. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis (Lond.), 17: 1595-1607, 1996
31. Munshi, N. C. Arsenic trioxide: an emerging therapy for multiple myeloma. Oncologist, 6: 17-21, 2001
32. Uslu, R., Sanli, U. A., Sezgin, C., Karabulut, B., Terzioglu, E., Omay, S. B., and Goker, E. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin. Cancer Res., 6: 4957-4964, 2000
33. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR α/PML proteins. Blood, 88: 1052-1061, 1996
34. 3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages. Leuk. Lymphoma, 38: 153-163, 2000
35. Schweichel, J. U., and Merker, H. J. The morphology of various types of cell death in prenatal tissues. Teratology, 7: 253-266, 1973
36. Yamamoto, A., Tagawa, Y., Yoshimori, T., Moriyama, Y., Masaki, R., and Tashiro, Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct., 23: 33-42, 1998